Tech Company Financing Transactions
Matchpoint Therapeutics Funding Round
On 10/17/2022, Matchpoint Therapeutics raised $100 million in investment from Access Biotechnology, Atlas Venture and Sanofi-Genzyme BioVentures.
Transaction Overview
Access Biotechnology (Lead Investor)
Atlas Venture (Lead Investor)
Sanofi-Genzyme BioVentures (Lead Investor)
Company Information
Cambridge, MA 02139
USA
Management Team
Browse more venture capital transactions:
Prev: 10/17/2022: Quantum Systems venture capital transaction
Next: 10/18/2022: Nitricity venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs